Regenerative medicine nears banner year with $14.1B cash infusion, regulatory milestones and a well-stocked pipeline

Gene therapies and gene-modified cell therapy products are on track to notch the highest annual number of regulatory approvals in 2021. (LuckyStep48/Getty Images)

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.